Solveig Sand-Hanssen Hofvind
Veronica Hernström,
Viktoria Josefsson,
Hanna Sartor,
David Schmidt,
Anna-Maria Larsson,
Solveig Sand-Hanssen Hofvind
m.fl.:
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
The Lancet Digital Health 2025
Susanne Fogh Jørgensen,
Silje Sagstad,
Javier Louro,
Marta Román,
Xavier Castells,
Solveig Sand-Hanssen Hofvind
m.fl.:
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain
Breast Cancer Research and Treatment 2024 /
Nataliia Moshina,
Axel Gräwingholt,
Kristina LÃ¥ng,
Ritse Mann,
Tone Hovda,
Solveig Kristin Roth Hoff
m.fl.:
Digital breast tomosynthesis in mammographic screening: false negative cancer cases in the To-Be 1 trial
Insights into Imaging 2024 / /
Åsne Sørlien Holen,
Marit Almenning Martiniussen,
Marie Burns Bergan,
Nataliia Moshina,
Tone Hovda,
Solveig Sand-Hanssen Hofvind
:
Women's attitudes and perspectives on the use of artificial intelligence in the assessment of screening mammograms
European Journal of Radiology 2024 /
Abhibhav Sharma,
Julia Debik,
Bjørn Naume,
Hege Oma Ohnstad,
Guro Kristine Kleivi Sahlberg,
Elin Borgen
m.fl.:
Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes
Oncogenesis 2024 /
Tone Hovda,
Silje Sagstad,
Nataliia Moshina,
Einar Vigeland,
Solveig Sand-Hanssen Hofvind
:
Initial interpretation scores of screening mammograms and cancer detection in BreastScreen Norway
European Journal of Radiology 2024 /
Jessie J. J. Gommers,
Craig K. Abbey,
Fredrik Strand,
Sian Taylor-Phillips,
David J. Jenkinson,
Marthe Larsen
m.fl.:
Modeling Radiologists’ Assessments to Explore Pairing Strategies for Optimized Double Reading of Screening Mammograms
Medical decision making 2024 /
Marthe Larsen,
Camilla Flåt Olstad,
Christoph I. Lee,
Tone Hovda,
Solveig Kristin Roth Hoff,
Marit Almenning Martiniussen
m.fl.:
Performance of an Artificial Intelligence System for Breast Cancer Detection on Screening Mammograms from BreastScreen Norway
Radiology: Artificial Intelligence (RAI) 10. april 2024 / /
Nadia Iqbal,
Paula Marianna Berstad,
Marit Solbjør,
Esperanza Diaz Perez,
Elzbieta Czapka,
Solveig Sand-Hanssen Hofvind
m.fl.:
Access to colorectal cancer screening for Pakistani immigrants in Norway – a qualitative study
BMC Health Services Research 2024 /
Sameer Bhargava,
Jonas Gjesvik,
Jonas Evensen Thy,
Marthe Larsen,
Solveig Sand-Hanssen Hofvind
:
Breast cancer-specific survival among immigrants and non-immigrants invited to BreastScreen Norway
Journal of Migration and Health 2024 /
Henrik Wethe Koch,
Marthe Larsen,
Hauke Bartsch,
Marit Almenning Martiniussen,
Bodil Margrethe Styr,
Siri Fagerheim
m.fl.:
How do AI markings on screening mammograms correspond to cancer location? An informed review of 270 breast cancer cases in BreastScreen Norway
European Radiology 2024
Cody M. Schopf,
Ojas A. Ramwala,
Kathryn P. Lowry,
Solveig Sand-Hanssen Hofvind,
M. Luke Marinovich,
Nehmat Houssami
m.fl.:
Artificial Intelligence-Driven Mammography-Based Future Breast Cancer Risk Prediction: A Systematic Review
Journal of the American College of Radiology 2024
Nataliia Moshina,
Marie Burns Bergan,
Åsne Sørlien Holen,
Gunhild Mangerud,
Solveig Sand-Hanssen Hofvind
:
Women's experience of the information provided along with invitation to participate in BreastScreen Norway
Journal of Medical Screening 2024 /
Jonas Gjesvik,
Nataliia Moshina,
Christoph I. Lee,
Diana L. Miglioretti,
Solveig Sand-Hanssen Hofvind
:
Artificial Intelligence Algorithm for Subclinical Breast Cancer Detection
JAMA Network Open 2024 /
Wanja Kildal,
Karolina Urszula Cyll,
Joakim Kalsnes,
Rakibul Islam,
Frida Marie Ihle Julbø,
Manohar Pradhan
m.fl.:
Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes
Heliyon 2024 /
Julie Røgler Langås,
Anne Eskild,
Solveig Sand-Hanssen Hofvind,
Elisabeth Krefting Bjelland
:
The association of adolescent to midlife weight change with age at natural menopause: a population study of 263,586 women in Norway
American Journal of Epidemiology 2024 /
Sameer Bhargava,
Mona Chakron,
Liv Halvorsrud,
Elżbieta Czapka,
Solveig Sand-Hanssen Hofvind
:
Polske kvinners opplevelse av Mammografiprogrammet
Sykepleien Forskning 2024
Nathalie Charlotte Støer,
Siri Vangen,
Deependra Singh,
Renee T. Fortner,
Solveig Hofvind,
Giske Ursin
m.fl.:
Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway
British Journal of Cancer 2024 /
Marie Burns Bergan,
Marthe Larsen,
Nataliia Moshina,
Hauke Bartsch,
Henrik Wethe Koch,
Hildegunn Siv Aase
m.fl.:
AI performance by mammographic density in a retrospective cohort study of 99,489 participants in BreastScreen Norway
European Radiology 2024
Kaitlyn Tsuruda,
Solveig Kristin Roth Hoff,
Lars Andreas Akslen,
Solveig Sand-Hanssen Hofvind
:
Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study
British Journal of Cancer 04. desember 2023 /
Helen Egestad,
Solveig Sand-Hanssen Hofvind,
Richard Fjellaksel
:
Utøvelse og utvikling av radiografifaget i Norge. En kvalitativ studie
Hold Pusten 18. desember 2023 /
Sisse Helle Njor,
Sirpa Heinävaara,
hrefna Stefansdóttir,
Mari Nygård,
Eva MarÃa Guðmundsdóttir,
Sameer Bhargava
m.fl.:
Differences in mammography screening attendance among non-Western immigrants in Denmark, Finland, Iceland and Norway
Preventive Medicine Reports 2023 /
Javier Louro,
Marta Román,
Nataliia Moshina,
Camilla Flåt Olstad,
Marthe Larsen,
Silje Sagstad
m.fl.:
Personalized Breast Cancer Screening: A Risk Prediction Model Based on Women Attending BreastScreen Norway
Cancers 2023 /
Anders Skyrud Danielsen,
Petter Elstrøm,
Hanne-Merete Eriksen-Volle,
Solveig Sand-Hanssen Hofvind,
David W. Eyre,
Oliver Kacelnik
m.fl.:
The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008–2018: expanding surveillance using existing laboratory and register data
European Journal of Clinical Microbiology and Infectious Diseases 2023 /
Anouk H. Eijkelboom,
Marthe Larsen,
Sabine Siesling,
Jan Franz Nygård,
Solveig Sand-Hanssen Hofvind,
Linda de Munck
:
Prolonged screening interval due to the COVID-19 pandemic and its association with tumor characteristics and treatment; a register-based study from BreastScreen Norway
Preventive Medicine 2023 /
Jessie J.J. Gommers,
Craig K. Abbey,
Fredrik Strand,
Sian Taylor-Phillips,
David J. Jenkinson,
Marthe Larsen
m.fl.:
Optimizing the Pairs of Radiologists That Double Read Screening Mammograms
Radiology 2023 /
Marthe Larsen,
Camilla Flåt Olstad,
Henrik Wethe Koch,
Marit Almenning Martiniussen,
Solveig Kristin Roth Hoff,
HÃ¥kon Lund-Hanssen
m.fl.:
AI Risk Score on Screening Mammograms Preceding Breast Cancer Diagnosis
Radiology 2023 / /
Tone Hovda,
Marthe Larsen,
Linda Romundstad,
Guro Kristine Kleivi Sahlberg,
Solveig Sand-Hanssen Hofvind
:
Breast cancer missed at screening; hindsight or mistakes?
European Journal of Radiology 2023 /
Marthe Larsen,
Elsebeth Lynge,
Christoph I. Lee,
Kristina LÃ¥ng,
Solveig Sand-Hanssen Hofvind
:
Mammographic density and interval cancers in mammographic screening: Moving towards more personalized screening
Breast 2023 /
Tone Hovda,
Silje Sagstad,
Marthe Larsen,
Yan Chen,
Solveig Sand-Hanssen Hofvind
:
Screening outcome for interpretation by the first and second reader in a population-based mammographic screening program with independent double reading
Acta Radiologica 2023 /
Li Zhang,
Isabel Mosquera,
Eric Lucas,
Mary Luz Rol,
Andre L. Carvalho,
Partha Basu
m.fl.:
CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs
Nature Medicine 2023
Gisella Figlioli,
Amandine Billaud,
Thomas U. Ahearn,
Natalia N. Antonenkova,
Heiko Becher,
Matthias W. Beckmann
m.fl.:
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
European Journal of Human Genetics 2023 /
Henrik Wethe Koch,
Marthe Larsen,
Hauke Bartsch,
Kathinka Dæhli Kurz,
Solveig Sand-Hanssen Hofvind
:
Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases
European Radiology 2023 /
Leif Lukas Löfling,
Nathalie Charlotte Støer,
Sara Nafisi,
Giske Ursin,
Solveig Sand-Hanssen Hofvind,
Edoardo Botteri
:
Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women
European Journal of Epidemiology (EJE) 2023 /
åsne Sørlien Holen,
Marie Burns Bergan,
Christoph I. Lee,
Sophia Zackrisson,
Nataliia Moshina,
Hildegunn Siv Aase
m.fl.:
Early screening outcomes before, during, and after a randomized controlled trial with digital breast tomosynthesis
European Journal of Radiology 2023 /
Jonas Evensen Thy,
Marthe Larsen,
Einar Vigeland,
Henrik Wethe Koch,
Tone Hovda,
Solveig Sand-Hanssen Hofvind
:
Early performance measures following regular versus irregular screening attendance in the population-based screening program for breast cancer in Norway
Journal of Medical Screening 2023 /
Marit Almenning Martiniussen,
Marthe Larsen,
Anne Sofie Frøyshov Larsen,
Tone Hovda,
Henrik Wethe Koch,
Atle Bjørnerud
m.fl.:
Norwegian radiologists’ expectations of artificial intelligence in mammographic screening – A cross-sectional survey
European Journal of Radiology 2023 /
Nataliia Moshina,
Silje Sagstad,
åsne Sørlien Holen,
Heinrich August Backmann,
Line Camilla Westermann,
Solveig Sand-Hanssen Hofvind
:
Experience of pain during mammographic screening by three different compression paddles
Radiography 2023 /
Kristina LÃ¥ng,
Viktoria Josefsson,
Anna-Maria Larsson,
Stefan Larsson,
Charlotte Högberg,
Hanna Sartor
m.fl.:
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
The Lancet Oncology 2023 /
Solveig Sand-Hanssen Hofvind,
Nadia Iqbal,
Jonas Evensen Thy,
Gunhild Mangerud,
Sameer Bhargava,
Sophia Zackrisson
m.fl.:
Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway
The BMJ 2023 /
Nataliia Moshina,
Heinrich August Backmann,
Per Skaane,
Solveig Sand-Hanssen Hofvind
:
Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996–2020
European Radiology 2023 /
Anouk H. Eijkelboom,
Linda de Munck,
Marthe Larsen,
Maarten J. Bijlsma,
Vivianne C.G. Tjan-Heijnen,
Carla H. van Gils
m.fl.:
Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study
Cancer Epidemiology 2023 /
Helen Egestad,
Solveig Sand-Hanssen Hofvind,
Richard Fjellaksel
:
Eksponert En podcast fra Norsk Radiografforbund
27. januar 2025 /
Robert Jenssen,
Rolf Ole Lindsetmo,
Therese Hoseth Blomsø,
Solveig Sand-Hanssen Hofvind,
Even A. Røed,
Mathias K. Hauglid
m.fl.:
Hvordan implementerer vi KI for bruk i helsesektoren på en trygg måte?
2024
Fredrik Andreas Dahl,
Olav Brautaset,
Marit Holden,
Line Eikvil,
Marthe Larsen,
Marit Almenning Martiniussen
m.fl.:
En to-trinns kunstig intelligens modell for deteksjon av brystkreft i mammogrammer
2024
Kaitlyn Tsuruda,
Hilde Langseth,
Giske Ursin,
Solveig Sand-Hanssen Hofvind,
Shannon Renee Turzanski Fortner
:
Validity of self-reported number of pregnancies and maternal age at first birth among females attending organized mammographic screening
Scandinavian Journal of Public Health 2024 /
Julie Røgler Langås,
Solveig Sand-Hanssen Hofvind,
Nathalie Charlotte Støer,
Anne Eskild,
Elisabeth Krefting Bjelland
:
Adolescent to midlife exercise trajectories and age at menopause: a population study of 246 147 women in Norway
Norsk Epidemiologi, Supplement 2024
Julie Røgler Langås,
Anne Eskild,
Solveig Sand-Hanssen Hofvind,
Elisabeth Krefting Bjelland
:
The association of adolescent to midlife weight change with age at natural menopause: a population study of 263,586 women in Norway.
Norsk Epidemiologi, Supplement 2024
Helen Egestad,
Solveig Sand-Hanssen Hofvind,
Richard Fjellaksel
:
Hold Pustens artikkelpris for 2023
Hold Pusten 2024
Julie Røgler Langås,
Anne Eskild,
Solveig Sand-Hanssen Hofvind,
Elisabeth Krefting Bjelland
:
The dose–response relationship of pre-menopausal alcohol consumption with age at menopause: a population study of 280 497 women in Norway
2023
